Bristol Myers Squibb (BMY): BMY PDUFA date for Mavacamten is 1/28/22...

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Re: DewDiligence post# 954

Friday, 03/19/2021 8:37:49 AM

Friday, March 19, 2021 8:37:49 AM

BMY PDUFA date for Mavacamten is 1/28/22:

https://www.businesswire.com/news/home/20210319005189/en

Mavacamten is the drug BMY got in the $13.1B acquisition of MYOK in Oct 2020 (#msg-158698900).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Keep Last Read

Replies (1) Next 10 Prev Next

Go Ad-Free